Foley Partner Antoinette Konski authored an article that appeared in the September 2011 issue of BioProcess International titled “Generic Biologics.” Konski reviews several key provisions of various regulatory pathways for generic biologics in the United States, China, India and throughout Europe, and discusses how these pathways could support biosimilar manufacturing.
